New lung support device helps ARDS patients breathe easier

NCT ID NCT04617093

Completed Disease control Sponsor: Vantive Health LLC Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 32 times

Summary

This study tested a device called PrismaLung+ that removes carbon dioxide from the blood in adults with mild to moderate acute respiratory distress syndrome (ARDS) who are on a breathing machine. The goal was to see if the device allows doctors to use gentler ventilator settings, which may reduce further lung damage. 63 participants were enrolled, and the study measured how many could safely achieve these gentler settings and tracked any side effects like bleeding.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MILD TO MODERATE ACUTE RESPIRATORY DISTRESS SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Investigational Site

Besançon, 25030, France
Investigational Site

Colombes, 92700, France
Investigational Site

Créteil, 94010, France
Investigational Site

Lille, 59037, France
Investigational Site

Marseille, 13354, France
Investigational Site

Montpellier, 34295, France
Investigational Site

Paris, 75013, France
Investigational Site

Paris, 75651, France
Investigational Site

Strasbourg, 67098, France
Investigational Site

Vandœuvre-lès-Nancy, 54511, France

Conditions

Explore the condition pages connected to this study.

MILD TO MODERATE ACUTE RESPIRATORY DISTRESS SYNDROME